Foghorn Therapeutics (FHTX) EBT Margin (2020 - 2026)
Foghorn Therapeutics' quarterly EBT Margin came in at 607.01% in Q1 2026, down 26727.0% year-on-year from N/an in Q1 2025, and down 153.23% quarter-over-quarter from 239.71% in Q4 2025.
Foghorn Therapeutics has reported EBT Margin for 7 years, with the latest figure at 607.01% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 26727.0% year-over-year to 607.01%; the trailing twelve-month figure through Mar 2026 stood at 273.72% (up 7441.0% YoY), and the FY2025 full-year result was 251.2%, up 13204.0% from the prior year.
- EBT Margin for Q1 2026 stood at 607.01%, down from 239.71% in the prior quarter.
- The five-year high for EBT Margin was 77.85% in Q3 2023, with the low at 690.39% in Q4 2022.
- Average EBT Margin over 5 years is 429.55%, with a median of 388.44% recorded in 2022.
- Year-over-year, EBT Margin jumped 6487985 bps in 2022 and plunged 29945 bps in 2024.
- Tracing FHTX's EBT Margin over 5 years: stood at 690.39% in 2022, then surged by 44 bps to 383.43% in 2023, then tumbled by 78 bps to 682.88% in 2024, then soared by 65 bps to 239.71% in 2025, then sank by 153 bps to 607.01% in 2026.
- The last three EBT Margin figures came in at 607.01% (Q1 2026), 239.71% (Q4 2025), and 202.0% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 18.99% |
| 10 | Foghorn Therapeutics | 297.63 Mn | 208.72 Mn | - | -607.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -607.01% |
| Dec 31, 2025 | -239.71% |
| Sep 30, 2025 | -202.00% |
| Jun 30, 2025 | -248.62% |
| Mar 31, 2025 | -339.73% |
| Dec 31, 2024 | -682.88% |
| Sep 30, 2024 | -244.90% |
| Jun 30, 2024 | -333.61% |
| Mar 31, 2024 | -495.37% |
| Dec 31, 2023 | -383.43% |
| Sep 30, 2023 | -77.85% |
| Jun 30, 2023 | -509.82% |
| Mar 31, 2023 | -563.72% |
| Dec 31, 2022 | -690.39% |
| Sep 30, 2022 | -388.44% |
| Jun 30, 2022 | -608.31% |
| Mar 31, 2022 | -686.58% |
| Dec 31, 2021 | -3,998.32% |
| Sep 30, 2021 | -65,268.29% |
| Jun 30, 2021 | -8,514.70% |
| Mar 31, 2021 | -8,257.34% |
| Dec 31, 2020 | -8,406.37% |
| Sep 30, 2020 | -10,441.90% |